Primary Hyperparathyroidism: Causes, Symptoms & Treatment

Primary hyperparathyroidism is a condition in which one or more of the four small parathyroid glands in your neck produce too much parathyroid hormone (PTH), driving blood calcium levels abnormally high. It is the most common cause of elevated calcium found on routine blood work, with an estimated incidence in the United States of about 66 per 100,000 person-years in women and 25 per 100,000 in men.¹ The disease has shifted dramatically in recent decades, from a rare condition that announced itself with severe bone disease and kidney stones to a milder, often quietly discovered abnormality on a chemistry panel. That shift makes the modern version both easier to catch and harder to understand, because many people feel fine at the time of diagnosis yet still face real long-term risks.

What Causes It

In roughly 80% of cases, a single benign tumor called a parathyroid adenoma is to blame. The gland enlarges and churns out PTH without responding normally to the body’s feedback signals. Parathyroid hyperplasia, where multiple glands enlarge, accounts for about 15% of cases. The remainder includes multifocal disease and, rarely, parathyroid carcinoma, which occurs in fewer than 1% of patients.²

At the molecular level, about 90% of these sporadic cases involve somatic mutations, meaning genetic changes that happen within the parathyroid cells themselves over a person’s lifetime rather than being inherited. Two genetic abnormalities stand out: loss-of-function mutations in the MEN1 gene, found in roughly 12–35% of sporadic adenomas, and overexpression of cyclin D1, found in 20–40%.² Exposure to ionizing radiation is also an established risk factor. Studies have found an elevated rate of parathyroid adenomas in people who received radiation to the head or neck region.³

A small percentage of cases are hereditary, linked to syndromes such as multiple endocrine neoplasia types 1 and 2A, or to mutations in the calcium-sensing receptor (CaSR). The CaSR sits on parathyroid cells and kidney tubules and acts like a thermostat for calcium. When it works properly, rising calcium levels tell the parathyroid glands to ease off PTH production. Loss-of-function mutations in this receptor can lead to conditions ranging from mild familial hypocalciuric hypercalcemia to severe neonatal hyperparathyroidism.⁴

How It Gets Discovered

Before the 1970s, doctors typically found primary hyperparathyroidism only after patients developed dramatic symptoms like severe bone pain, pathological fractures, or recurrent kidney stones. Then automated blood chemistry panels became standard practice, and routine calcium measurements began catching the disease much earlier.¹ Today, most people in developed countries are diagnosed when a blood test shows elevated calcium, prompting their doctor to check PTH levels. If both calcium and PTH are elevated at the same time, that combination is the hallmark of primary hyperparathyroidism, because normal physiology would suppress PTH when calcium is high.

This pattern is not universal worldwide. In parts of South Asia and other regions where routine calcium screening is less common, patients still tend to present with the classic symptomatic disease, including significant bone involvement and kidney complications.⁵

Symptoms You Might Notice and Those You Might Not

The textbook mnemonic is “bones, stones, abdominal moans, and psychic groans,” and while it is catchy, the reality for many people today is subtler than that suggests. Some patients feel entirely well. Others have vague complaints that never seemed worth investigating until the lab work came back abnormal.

Fatigue is one of the most common presenting symptoms. It can be significant enough to erode quality of life, yet because it is so nonspecific, many patients go years without anyone connecting their tiredness to a parathyroid problem.⁶ Cognitive symptoms round out the picture: difficulty concentrating, memory lapses, and a general sense of mental fog. One study that objectively measured neurocognitive function found that about 44% of patients showed dysfunction before surgery, dropping to about 22% after parathyroidectomy. Executive function, in particular, improved significantly.⁷

Other symptoms people report include muscle weakness, joint pain, increased thirst and urination, constipation, and depressed mood. Because these complaints overlap with so many other conditions, a calcium check is the single most useful screening step if you have a handful of these symptoms without an obvious explanation.

What Happens to Your Bones

PTH, in short bursts, actually stimulates bone formation. That is why a synthetic form of PTH is sometimes used as a treatment for osteoporosis. But when PTH stays high around the clock, as it does in primary hyperparathyroidism, the net effect flips: bone breakdown outpaces building. The damage, however, is uneven. Cortical bone, the dense outer shell found especially in the forearm and hip, takes the biggest hit. Trabecular bone, the spongy interior found predominantly at the spine, has traditionally appeared relatively preserved on standard bone density scans.⁸ ⁹

That neat division turns out to be somewhat misleading. When researchers used high-resolution imaging that can see individual bone struts rather than just average density, they found that postmenopausal women with primary hyperparathyroidism had thinner cortices, lower trabecular density, and more widely spaced and unevenly distributed trabeculae at both the wrist and the ankle compared with controls. Fracture risk was increased at both vertebral and nonvertebral sites, suggesting the damage is more pervasive than standard bone density scans reveal.¹⁰

Kidney Complications

The kidneys bear a double burden. Excess PTH directly increases how much calcium the kidneys reabsorb, but the overall load of filtered calcium still rises because serum calcium is so high. The result can be kidney stones (nephrolithiasis), calcium deposits within the kidney tissue itself (nephrocalcinosis), and a gradual decline in kidney function.¹¹ ¹²

In one retrospective study of 145 patients, about 30% had an estimated glomerular filtration rate below the threshold considered mild kidney impairment. High calcium levels and coexisting high blood pressure were strongly linked to the renal dysfunction.¹³ Kidney stones alone drive many patients to seek treatment, and the presence of stones or nephrocalcinosis is one of the clearest indications for surgery.

Cardiovascular and Metabolic Risks

The relationship between primary hyperparathyroidism and the heart is real but complicated. High calcium and high PTH both appear to affect blood vessel walls and heart muscle cells, and epidemiological data have linked untreated disease with increased cardiovascular mortality.¹⁴ However, studies have produced conflicting results on exactly which cardiovascular problems are more common, partly because patient populations differ in age, sex, and how high their calcium levels run.¹⁵

A large cohort study comparing patients with primary hyperparathyroidism to matched controls found elevated long-term risks for hypertension, type 2 diabetes, cardiovascular disease, and cerebrovascular events, with adjusted hazard ratios ranging from about 1.07 for type 2 diabetes to about 1.28 for cardiovascular disease.¹⁶ Those are modest but meaningful increases, especially over years or decades. Whether surgery reverses these risks remains an active area of debate, particularly for hypertension, which often persists after parathyroidectomy even when calcium levels normalize.

Pancreatitis and Digestive Symptoms

Acute pancreatitis is an uncommon but well-documented complication. High calcium levels can trigger premature activation of digestive enzymes inside the pancreas, essentially causing it to start digesting itself. Calcium deposits may also obstruct pancreatic ducts, and some patients carry additional genetic susceptibility factors that, combined with hypercalcemia, tip them toward an attack.¹⁷ ¹⁸ In some cases, pancreatitis is actually the event that uncovers an underlying parathyroid problem for the first time.

The Normocalcemic Variant

A puzzling form of the disease has gained attention in recent years: normocalcemic primary hyperparathyroidism. In these patients, PTH is persistently elevated but serum calcium stays within the normal range. Because the usual diagnostic red flag of high calcium is absent, these cases are easy to miss.¹⁹

The challenge with normocalcemic hyperparathyroidism is distinguishing it from secondary causes of elevated PTH, such as low vitamin D levels or chronic kidney disease, which are far more common. One study that followed patients initially labeled as having normocalcemic hyperparathyroidism found that over half ultimately turned out to have secondary hyperparathyroidism, while about 19% progressed to classic high-calcium disease.²⁰ Despite their normal calcium, people who do have the primary form develop complications at rates similar to those with the classic version, including osteoporosis, kidney stones, and gastrointestinal disorders.²¹ That means the condition is not simply a harmless early stage, and it requires careful follow-up.

Ruling Out a Common Mimic

One condition that closely resembles primary hyperparathyroidism on blood tests is familial hypocalciuric hypercalcemia (FHH). People with FHH have mildly elevated calcium and normal-to-mildly elevated PTH, which looks a lot like mild primary hyperparathyroidism. The critical difference: FHH is a benign genetic condition caused by an inherited mutation in the calcium-sensing receptor, and surgery does not help. Operating on someone with FHH is all risk and no benefit.

The traditional way to tell them apart is a urine test that calculates how efficiently the kidneys are clearing calcium relative to creatinine. In FHH, the kidneys hold on to calcium unusually tightly, so urinary calcium excretion is low. But there is an overlap zone where the test is inconclusive, and definitive diagnosis of FHH can require genetic testing.²² ²³ For this reason, a 24-hour urine collection for calcium and creatinine should be part of the initial workup whenever primary hyperparathyroidism is suspected, especially in patients with mild or asymptomatic disease.

Locating the Problem Before Surgery

Once surgery is decided on, imaging helps the surgeon know where to look. People have four parathyroid glands, but they can sit in variable locations, and only the abnormal one (or ones) need to come out. Two imaging approaches form the backbone of preoperative localization: neck ultrasound and nuclear medicine scanning with 99mTc-sestamibi, often combined with single-photon emission computed tomography (SPECT/CT). The sestamibi tracer is taken up by cells with abundant mitochondria, which parathyroid adenomas happen to have in spades.²⁴

Neither test is perfect on its own. In a large study of over 1,000 patients, neither ultrasound nor sestamibi scanning detected any abnormal gland in roughly 22–28% of patients, and sensitivity varied considerably depending on the gland’s position. Combining both modalities improved results, with one study reporting an overall sensitivity of 95% and accuracy of 91% for solitary adenomas.²⁵ ²⁶ Newer techniques, including four-dimensional CT (4DCT), MRI with dynamic contrast, and PET/CT with fluorocholine tracers, are increasingly used when the standard tests fail to pinpoint the gland, though 4DCT delivers a higher radiation dose to the thyroid and is not always the best first choice.²⁴

When Surgery Is Recommended

Parathyroidectomy is the only cure for primary hyperparathyroidism, and international guidelines are clear that it can be offered to any patient who is a reasonable surgical candidate. That said, the guidelines also identify specific situations where surgery is particularly recommended, even in patients without obvious symptoms. The most recent international workshop criteria include:

Elevated calcium: serum calcium more than 1 mg/dL above the upper limit of normal
Bone involvement: a bone density T-score of −2.5 or lower at any site, or a vertebral fracture found on imaging
Kidney involvement: reduced kidney function (eGFR below 60), kidney stones, nephrocalcinosis, or excess urinary calcium
Age under 50: younger age alone is considered sufficient reason, even without other criteria

Meeting even one of these criteria is enough to recommend surgery.²⁷ For patients who do not meet any criteria and feel well, the alternative is active monitoring with periodic calcium levels, bone density scans, and kidney function checks.²⁸

What Surgery Looks Like

Modern parathyroid surgery in experienced hands is a relatively quick procedure, often performed through a small incision under general or even local anesthesia with sedation. When imaging has successfully identified a single adenoma, the surgeon can perform a focused, minimally invasive parathyroidectomy rather than exploring all four glands.

A key tool during the operation is intraoperative PTH monitoring. Because PTH has a short half-life in the blood, levels drop rapidly once the overactive gland is removed. The surgeon draws blood samples before and after excision, and a drop of more than 50% from baseline within about 10 minutes is strong confirmation that all hyperfunctioning tissue has been taken out. Using this criterion, sensitivity runs around 96% with accuracy near 94–95%.²⁹ If levels do not fall enough, the surgeon knows to keep looking for additional abnormal tissue. A systematic review and meta-analysis confirmed that this real-time monitoring significantly reduces the rate of persistent or recurrent disease after surgery.³⁰

Medical Alternatives for People Who Cannot Have Surgery

Not everyone is a candidate for an operation. Some patients have surgical contraindications, some decline the procedure, and some have mild disease that does not meet criteria. For these individuals, two classes of medication can help manage specific aspects of the condition, though neither replaces surgery as a cure.

Cinacalcet works by making the calcium-sensing receptor on parathyroid cells more sensitive, essentially tricking them into thinking calcium is higher than it is. It is effective at lowering serum calcium to normal in many patients, but it has only a modest effect on PTH levels and does not improve bone density. For bone protection, bisphosphonates like alendronate are the go-to option, as they can increase bone density at the spine, though they do not lower calcium. Using both drugs together is a reasonable approach in theory, but strong evidence for the combination is still limited.³¹

Hungry Bone Syndrome After Surgery

An uncommon but serious complication to be aware of after parathyroidectomy is hungry bone syndrome. During the period of excess PTH, bone has been breaking down faster than it builds. Once the offending gland is removed and PTH drops sharply, the skeleton suddenly shifts into aggressive rebuilding mode and starts pulling calcium, phosphorus, and magnesium out of the bloodstream faster than the body can replace them. The result is a rapid, sometimes severe drop in blood calcium that can cause tingling, muscle cramps, and in serious cases, cardiac arrhythmias.³²

Hungry bone syndrome is more likely in patients who had particularly high PTH and calcium levels before surgery, or who had evidence of high bone turnover. It requires close monitoring in the days after the operation and sometimes weeks of aggressive calcium and vitamin D supplementation to keep levels safe while the skeleton catches up.³³

Primary Hyperparathyroidism During Pregnancy

Although uncommon, primary hyperparathyroidism in pregnancy carries disproportionate risks because the fetus is sensitive to maternal calcium levels. A high maternal calcium can suppress the developing baby’s own parathyroid glands, and after birth, the newborn may develop dangerous low calcium levels and seizures. In one case series, a third of patients presented only after their newborns developed hypocalcemic convulsions, meaning the mother’s condition had gone unrecognized throughout pregnancy.³⁴

Serious maternal complications can also occur, including hypercalcemic crisis, pancreatitis, and preeclampsia. When surgery is needed during pregnancy, minimally invasive parathyroidectomy under cervical plexus block (avoiding general anesthesia) has been performed successfully. The second trimester is generally considered the safest window for operating, balancing the risks of anesthesia and the risks of leaving hypercalcemia untreated.³⁴

1
JAMA. Diagnosis and Management of Primary Hyperparathyroidism
2
SpringerOpen / Hormones (Athens). Genetics of hereditary forms of primary hyperparathyroidism – Section: Introduction
3
PubMed. Increased incidence of parathyroid adenomas following X-ray treatment of benign diseases in the cervical spine in adult patients
4
PubMed Central. Calcium-sensing receptor: Role in health and disease
5
PubMed Central. Changes in clinical & biochemical presentations of primary hyperparathyroidism in India over a period of 20 years
6
PubMed. Tired of Being Ignored: Fatigue as a Presenting Symptom in Primary Hyperparathyroidism
7
PubMed. Objectively measured cognitive dysfunction in patients with primary hyperparathyroidism improves after parathyroidectomy
8
PubMed Central. Bone disease in primary hyperparathyrodism
9
Journal of Bone and Mineral Research. Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: A case‐control study using HR‐pQCT
10
Journal of Bone and Mineral Research. Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women
11
PubMed Central. Renal manifestations of primary hyperparathyroidism
12
The Journal of Clinical Endocrinology & Metabolism. Nephrolithiasis and Renal Calcifications in Primary Hyperparathyroidism
13
PubMed. Renal dysfunction in primary hyperparathyroidism; effect of Parathyroidectomy: A retrospective Cohort Study
14
PubMed Central. Primary hyperparathyroidism and hypertension
15
The Journal of Clinical Endocrinology & Metabolism. Cardiovascular Involvement in Primary Hyperparathyroidism
16
JAMA Network Open. Parathyroidectomy and Cardiometabolic Risks in Patients With Primary Hyperparathyroidism
17
Endocrine Abstracts. Acute pancreatitis revealing hyperparathyroidism: an unusual presentation: three case reports and literature review
18
PubMed Central. The association of primary hyperparathyroidism with pancreatitis
19
PubMed. Normocalcemic primary hyperparathyroidism: From pathophysiology to clinical management
20
PubMed. Normocalcemic hyperparathyroidism: Intervention to differentiate primary from secondary hyperparathyroidism
21
PubMed. Biochemical characteristics and clinical manifestation of normocalcemic primary hyperparathyroidism
22
PubMed. Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism
23
PubMed Central. Familial hypocalciuric hypercalcemia and related disorders
24
PubMed Central. Parathyroid Imaging: Past, Present, and Future
25
PubMed. Accuracy of Parathyroid Adenoma Localization by Preoperative Ultrasound and Sestamibi in 1089 Patients with Primary Hyperparathyroidism
26
PubMed. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism
27
Journal of Bone and Mineral Research. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop – Section: Surgical Aspects of PHPT
28
PubMed Central. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop
29
JAMA Surgery. An Optimal Algorithm for Intraoperative Parathyroid Hormone Monitoring
30
International Journal of Surgery. The role of Rapid Intraoperative Parathyroid Hormone (ioPTH) assay in determining outcome of parathyroidectomy in primary hyperparathyroidism: A systematic review and meta-analysis
31
The Journal of Clinical Endocrinology & Metabolism. Medical Management of Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism
32
European Journal of Endocrinology. Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature
33
PubMed Central. Lessons learned from the management of Hungry Bone Syndrome following the removal of an Atypical Parathyroid Adenoma
34
PubMed Central. Clinical Presentation, Management, and Outcomes of Primary Hyperparathyroidism during Pregnancy